Tag: cronos group

Cowen & Co. increased its estimates for the US cannabis market, expecting $85 billion in sales by 2030. Its previous sales forecast was $80 billion.

Cronos Group (CRON) reported its third-quarter earnings on November 12. The company missed analysts' revenue and EBITDA estimates for the quarter.

This week has been tough for the cannabis sector. Cronos Group and Canopy Growth reported lower-than-expected earnings, and the sector ETFs dropped.

It’s been quite the whipsaw week for cannabis stocks, to put it mildly. First, there was the “Drake spike.” Then came the earnings disappointments.

For the last few months, there's been weakness in the cannabis sector. Investors were hoping for Canopy Growth and Aurora Cannabis to bring some relief.

After falling for the first two days this week, the cannabis sector maintained that weakness today. Let's look at some cannabis stocks that are in the news.

After Cronos Group (CRON) reported its third-quarter earnings results yesterday, its stock closed at 10.40 Canadian dollars on the Toronto Stock Exchange.

In today’s Get Real, we saw Jamie Dimon's stance on Trump's tariffs and Kansas' stance on cannabis. Plus, updates on Tesla's Chinese presence.

Prohibition Partners expects that by 2024, the legal cannabis market could reach $103.9 billion and the medical cannabis market could reach $62.6 billion.

This year, Aurora Cannabis (ACB) has lost 30.5% of its stock value as of Thursday. Should you start to consider buying the stock? Jim Cramer doesn't think so.